Search Results - "SWART, Martha"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Coadministration of Oral Cyclosporin A Enables Oral Therapy with Paclitaxel by TERWOGT, J. M. M, MALINGRE, M. M, BEIJNEN, J. H, TEN BOKKEL HUININK, W. W, ROSING, H, KOOPMAN, F. J, VAN TELLINGEN, O, SWART, M, SCHELLENS, J. H. M

    Published in Clinical cancer research (01-11-1999)
    “…i.v. paclitaxel is inconvenient and associated with significant and poorly predictable side effects largely due to the pharmaceutical vehicle Cremophor EL…”
    Get full text
    Journal Article
  2. 2

    Phase I and Pharmacokinetic Study of Oral Paclitaxel by MALINGRE, M. M, TERWOGT, J. M. M, SCHELLENS, J. H. M, BEIJNEN, J. H, ROSING, H, KOOPMAN, F. J, VAN TELLINGEN, O, DUCHIN, K, TEN BOKKEL HUININK, W. W, SWART, M, LIEVERST, J

    Published in Journal of clinical oncology (01-06-2000)
    “…To investigate dose escalation of oral paclitaxel in combination with dose increment and scheduling of cyclosporine (CsA) to improve the systemic exposure to…”
    Get full text
    Journal Article
  3. 3

    Phase I Clinical and Pharmacokinetic Study of Oral S-1 in Patients With Advanced Solid Tumors by VAN GROENINGEN, C. J, PETERS, G. J, GIACCONE, G, SCHORNAGEL, J. H, GALL, H, NOORDHUIS, P, DE VRIES, M. J, TURNER, S. L, SWART, M. S, PINEDO, H. M, HANAUSKE, A. R

    Published in Journal of clinical oncology (01-07-2000)
    “…To investigate the side effects, determine the maximum-tolerated dose (MTD), and study the pharmacokinetics of S-1, an oral fluoropyrimidine-based…”
    Get full text
    Journal Article
  4. 4

    Phase I and Pharmacokinetic Study of Irinotecan Administered as a Low-Dose, Continuous Intravenous Infusion Over 14 Days in Patients With Malignant Solid Tumors by HERBEN, V. M. M, SCHELLENS, J. H. M, SWART, M, GRUIA, G, VERNILLET, L, BEIJNEN, J. H, TEN BOKKEL HUININK, W. W

    Published in Journal of clinical oncology (01-06-1999)
    “…To evaluate the feasibility of administering irinotecan as a continuous intravenous infusion for 14 to 21 days. Patients with solid tumors refractory to…”
    Get full text
    Journal Article
  5. 5

    A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A by MALINGRE, Mirte M, BEIJNEN, Jos H, ROSING, Hilde, KOOPMAN, Franciska J, VAN TELLINGEN, Olaf, DUCHIN, Ken, TEN BOKKEL HUININK, Wim W, SWART, Martha, LIEVERST, Jan, SCHELLENS, Jan H. M

    Published in Cancer chemotherapy and pharmacology (01-04-2001)
    “…To investigate dose escalation of bi-daily (b.i.d.) oral paclitaxel in combination with cyclosporin A in order to improve and prolong the systemic exposure to…”
    Get full text
    Journal Article
  6. 6

    The effect of different doses of cyclosporin A on the systemic exposure of orally administered paclitaxel by Malingré, Mirte M, Beijnen, Jos H, Rosing, Hilde, Koopman, Franciska J, van Tellingen, Olaf, Duchin, Ken, ten Bokkel Huinink, Wim W, Swart, Martha, Lieverst, Jan, Schellens, Jan HM

    Published in Anti-cancer drugs (01-04-2001)
    “…The objective of this study was to define the minimally effective dose of cyclosporin A (CsA) that would result in a maximal increase of the systemic exposure…”
    Get full text
    Journal Article
  7. 7

    Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administration by Malingré, Mirte M, Schellens, Jan HM, van Tellingen, Olaf, Rosing, Hilde, Koopman, Franciska J, Duchin, Ken, ten Bokkel Huinink, Wim W, Swart, Martha, Beijnen, Jos H

    Published in Anti-cancer drugs (01-11-2000)
    “…The objective of this study was to compare the quantitative excretion of paclitaxel and metabolites after i.v. and oral drug administration. Four patients…”
    Get full text
    Journal Article
  8. 8

    PHARMACOKINETICS OF PACLITAXEL ADMINISTERED AS A 3-HOUR OR 96-HOUR INFUSION by PANDAY, VINODH R.NANNAN, HUININK, WIM W.TEN BOKKEL, VERMORKEN, JAN B., ROSING, HILDE, KOOPMAN, FRANCISCA J., SWART, MARTHA, SCHELLENS, JAN H.M., BEIJNEN, JOS H.

    Published in Pharmacological research (01-07-1999)
    “…Aim: To investigate the pharmacokinetics of paclitaxel (PaxeneTM) administered to patients with advanced breast or ovarian cancer and to document safety and…”
    Get full text
    Journal Article
  9. 9

    A Population Vulnerability Analysis of South African Black Rhinoceros Diceros Bicornis by Swart, Martha Katharina Johanna

    Published 01-01-1994
    “…To determine the vulnerability of black rhinoceros populations in South Africa it was necessary to study all aspects of population biology. Since most of the…”
    Get full text
    Dissertation
  10. 10

    n Genetiese Evaluering Van Nege reënboogforelbevolkings in Suid-Afrika by Swart, Martha Katharina Johanna

    Published 01-01-1990
    “…Fishery managers work toward effective management of fishery resources in the face of diverse demands for recreational fishing and preservation of genetic…”
    Get full text
    Dissertation